During the past decade, Christine Thai, MD conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Christine Thai, MD" are "Arthritis" (1 trials), "Autoimmune Diseases" (1 trials), "Connective Tissue Diseases" (1 trials), "Immune System Diseases" (1 trials) and "Joint Diseases" (1 trials). Many other conditions were trialed in "Christine Thai, MD" in a lesser frequency.

Most popular intervention types in "Christine Thai, MD" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Afimetoran" (1 trials) and "Peresolimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christine Thai, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Christine Thai, MD". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Christine Thai, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Christine Thai, MD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".